Risk benefit analysis to evaluate risk of thromboembolic events after mRNA COVID-19 vaccination and COVID-19 is a research paper published in npj Vaccines (2024). On theSindex it has a DataRank of 0. It has been cited 8 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Foundation for the National Institutes of Health
Grant: R01AI158543
National Institutes of Health
Grant: 7R01AI158543-03
Incorporation of multilevel ontologies of adverse events and vaccines for vaccine safety surveillance
FWCI
3.32
Citation Percentile
0.9%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals